Reports of Encephalopathy Among Children with Influenza-Associated Mortality - United States, 2010-11 Through 2024-25

Amara Fazal1, Katie Reinhart1, Stacy Huang1

  • 1Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.

Insights

Severe influenza-associated encephalopathy or encephalitis (IAE) in children, including acute necrotizing encephalopathy (ANE), has been reported. Early evaluation, testing, and antiviral treatment are crucial for suspected cases.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Public Health Surveillance

Background:

  • Anecdotal reports of severe influenza-associated acute necrotizing encephalopathy (ANE) in children emerged in early 2025.
  • Influenza-associated encephalopathy or encephalitis (IAE) is a serious complication of influenza infection in pediatric populations.
  • Existing surveillance systems may not fully capture the incidence of IAE and ANE.

Purpose of the Study:

  • To examine trends in influenza-associated encephalopathy or encephalitis (IAE) among pediatric deaths.
  • To analyze the demographic and clinical characteristics of children with fatal IAE.
  • To inform healthcare providers about the recognition and management of IAE/ANE.

Main Methods:

  • Analysis of pediatric influenza-associated deaths from the 2010-11 through 2024-25 influenza seasons.
  • Review of case data for the presence of influenza-associated encephalopathy or encephalitis (IAE).
  • Contacting state health departments for specific case ascertainment, including ANE diagnoses.

Main Results:

  • IAE was identified in 9% (166/1840) of pediatric influenza-associated deaths across seasons (2010-11 to 2024-25).
  • Preliminary 2024-25 data show 13% (9/68) of pediatric influenza deaths had IAE.
  • Patients with fatal IAE were median 6 years old, 54% had no underlying conditions, and 20% were vaccinated.

Conclusions:

  • Influenza-associated encephalopathy or encephalitis (IAE) represents a significant proportion of pediatric influenza deaths.
  • Healthcare providers should maintain a high index of suspicion for IAE in children with acute febrile illness and neurological symptoms.
  • Prompt diagnosis, influenza testing, neuroimaging, antiviral therapy, and supportive care are critical. Annual influenza vaccination is recommended.